LIGAND PHARMACEUTICALS INC
LGNXZDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
lasofoxifene | Phase 2 | Osteoporosis | - | - |
Frequently asked questions
What is in LIGAND PHARMACEUTICALS INC's drug pipeline?→
CatalystAlert tracks 1 drug candidate in LIGAND PHARMACEUTICALS INC's (LGNXZ) pipeline across Phase 2. Its lead program is lasofoxifene (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is LIGAND PHARMACEUTICALS INC's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for LIGAND PHARMACEUTICALS INC (LGNXZ) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track LGNXZ biotech catalysts?→
Add LGNXZ to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow LIGAND PHARMACEUTICALS INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.